Johan Fevery
- Hepatology top 0.1%
- Liver Disease and Transplantation 77
- Hepatitis C virus research 32
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 87
- Hepatitis B Virus Studies 41
-
- Neonatal Health and Biochemistry 79
- Pharmacology top 0.5%
- Surgery top 1%
- Organ Transplantation Techniques and Outcomes 28
- Pediatric Hepatobiliary Diseases and Treatments 25
-
- Heme Oxygenase-1 and Carbon Monoxide 53
- Co-authors
- Frederik NevensKarel P.M. HeirweghJ. De GrooteChris VerslypeNorbert BlanckaertTania RoskamsWerner Van SteenbergenValeer Desmet
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Johan Fevery
325 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Hepatology 4.6k
- Epidemiology 4.1k
- Pediatrics, Perinatology and Child Health 1.9k
- Pharmacology 654
- Surgery 2.8k
Countries citing papers authored by Johan Fevery
This map shows the geographic impact of Johan Fevery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Fevery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Fevery more than expected).
Fields of papers citing papers by Johan Fevery
This network shows the impact of papers produced by Johan Fevery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Fevery. The network helps show where Johan Fevery may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Johan Fevery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 34 | |
| 2 | Nitroflurbiprofen (HCT-1026), a nitric oxidereleasing cyclooxygenase-inhibitor, improves cirrhotic portal hypertension in the rat without major side-effects | 2006 | 1 |
| 3 | Effect of MARS and prometheus on systemic hemodynamics and vasoactive substances in patients with acute-on-chronic alcoholic liver failure: The clash of the titans | 2005 | 1 |
| 4 | Hypothermic machine persfusion of porcine livers | 2005 | 2 |
| 5 | Machine perfusion of marginal livers | 2005 | 1 |
| 6 | Central role of Kupffer cell in ischemic injury following transplantation of non-heart-beating livers | 2005 | 0 |
| 7 | 2004 | 46 | |
| 8 | TT virus infection in acute and chronic liver diseases and in patients regularly receiving blood products in Belgium. | 2004 | 11 |
| 9 | Detectie van alcoholmisbruik of -afhankelijkheid in de huisartsenpraktijk | 2002 | 1 |
| 10 | Addition of epoprostenol (Epo) into the pressurized UW reduces the incidence of biliary stricture (BS) after liver transplantation (LTX) | 2001 | 1 |
| 11 | Patients transplanted for hepatitis C should not receive livers from older donors | 2001 | 2 |
| 12 | In vitro assays for drug testing: continuous cell lines. | 2000 | 2 |
| 13 | Non-surgical treatment of hepatocellular carcinoma (HCC). | 2000 | 4 |
| 14 | Validation of immunohistochemical staining with the monoclonal antibody 17H10 in liver biopsies for the diagnosis of chronic hepatitis C | 2000 | 4 |
| 15 | The level of variceal pressure is a mayor predictor for variceal hemorrhage both in patients with cirrhosis as in patients with non-cirrhotic portal hypertension | 1998 | 1 |
| 16 | Glucagon enhances bile flow, bilirubin uridine diphosphate-glucuronyltransferase activity and biliary bilirubin monoconjugate excretion in the rat. | 1992 | 3 |
| 17 | Detection of HCV antigen by immunohistochemical staining: a histological marker of HCV infection | 1991 | 2 |
| 18 | HLA-DR expression in Hepatitis B Virus infection | 1987 | 1 |
| 19 | 1987 | 22 | |
| 20 | Some pathophysiological aspects of cholestasis. | 1979 | 1 |
About Johan Fevery
Johan Fevery is a scholar working on Hepatology, Pediatrics, Perinatology and Child Health and Epidemiology, having authored 335 papers that have together received 9.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (87 papers), Neonatal Health and Biochemistry (79 papers), Liver Disease and Transplantation (77 papers), Heme Oxygenase-1 and Carbon Monoxide (53 papers), Hepatitis B Virus Studies (41 papers), Hepatitis C virus research (32 papers), Organ Transplantation Techniques and Outcomes (28 papers) and Pediatric Hepatobiliary Diseases and Treatments (25 papers). The work is most often cited by research in Hepatology (4.6k citations), Epidemiology (4.1k citations) and Pediatrics, Perinatology and Child Health (1.9k citations). Johan Fevery has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Frederik Nevens, Karel P.M. Heirwegh, J. De Groote, Chris Verslype, Norbert Blanckaert, Tania Roskams, Werner Van Steenbergen, Valeer Desmet, Kirsten Muri Boberg and David M. Nagorney. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, European Journal of Gastroenterology & Hepatology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.